The Latest Breaking News on Pharma

But does everyone really need to get boosted?

After August’s mixed tally for Food and Drug Administration approvals, investors turn to a new month, which has a fairly loaded calendar.

COVID-19 boosters from Moderna Inc. and the partnership of Pfizer Inc. and BioNTech SE that are tailored to the latest COVID-19 omicron variants got U.S. regulatory clearance, a move toward additional protection as concern grows about potential new waves in the fall and winter.

Omicron booster shots could become available within days

The updated shots are expected to become available after Labor Day.

U.S. regulators have authorized updated COVID-19 boosters, the first to directly target today's most common omicron strain

The COVID-19 virus's course and evolution remain unpredictable. But this far into the pandemic, there are some safe assumptions.

Cybin Inc.

The Food and Drug Administration is set to approve new boosters that specifically target the omicron mutation of COVID-19.

While the COVID-19 pandemic benefitted Johnson & Johnson (JNJ) and Pfizer (PFE) significantly as their vaccines helped the world recover from the crisis, these stocks are more than just COVID-19 plays because of their strong product portfolio and pipeline. They are well-positioned to capitalize on the rising chronic diseases, an…

Intensive innovation, breakthrough developments, and growing investments should help the biotech industry witness solid growth over the next decade. And given the sector’s reputation as a safe haven amid economic turmoil, it could be wise for investors to buy and hold fundamentally solid biotech stocks Amgen (AMGN) and AstraZeneca (AZN)…